首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   6391篇
  免费   544篇
  国内免费   16篇
耳鼻咽喉   33篇
儿科学   318篇
妇产科学   170篇
基础医学   816篇
口腔科学   152篇
临床医学   455篇
内科学   1307篇
皮肤病学   168篇
神经病学   1020篇
特种医学   414篇
外国民族医学   2篇
外科学   550篇
综合类   164篇
预防医学   711篇
眼科学   50篇
药学   358篇
中国医学   1篇
肿瘤学   262篇
  2021年   83篇
  2020年   64篇
  2019年   72篇
  2018年   87篇
  2017年   63篇
  2016年   83篇
  2015年   102篇
  2014年   119篇
  2013年   191篇
  2012年   307篇
  2011年   271篇
  2010年   180篇
  2009年   148篇
  2008年   266篇
  2007年   292篇
  2006年   261篇
  2005年   247篇
  2004年   251篇
  2003年   238篇
  2002年   221篇
  2001年   189篇
  2000年   172篇
  1999年   166篇
  1998年   98篇
  1997年   76篇
  1996年   66篇
  1995年   62篇
  1994年   55篇
  1993年   80篇
  1992年   167篇
  1991年   145篇
  1990年   137篇
  1989年   157篇
  1988年   160篇
  1987年   139篇
  1986年   130篇
  1985年   116篇
  1984年   111篇
  1983年   86篇
  1982年   63篇
  1981年   63篇
  1980年   61篇
  1979年   88篇
  1978年   48篇
  1977年   73篇
  1976年   52篇
  1974年   65篇
  1973年   69篇
  1971年   47篇
  1969年   52篇
排序方式: 共有6951条查询结果,搜索用时 15 毫秒
1.
2.
3.

Objective

To determine whether differences in combination DTaP vaccine types at 2, 4 and 6?months of age were associated with mortality (all-cause or non-specific), within 30?days of vaccination.

Design

Observational nationwide cohort study.

Setting

Linked population data from the Australian Childhood Immunisation Register and National Death Index.

Participants

Australian infants administered a combination trivalent, quadrivalent or hexavalent DTaP vaccine (DTaP types) between January 1999 and December 2010 at 2, 4 and 6?months as part of the primary vaccination series. The study population included 2.9, 2.6, & 2.3?million children in the 2, 4 and 6?month vaccine cohorts, respectively.

Main outcome measures

Infants were evaluated for the primary outcome of all-cause mortality within 30?days. A secondary outcome was non-specific mortality (unknown cause of death) within 30?days of vaccination. Non-specific mortality was defined as underlying or other cause of death codes, R95 ‘Sudden infant death syndrome’, R96 ‘Other sudden death, cause unknown’, R98 ‘Unattended death’, R99 ‘Other ill-defined and unspecified cause of mortality’ or where no cause of death was recorded.

Results

The rate of 30?day all-cause mortality was low and declined from 127.4 to 59.3 deaths per 100,000 person-years between 2 and 6?month cohorts. When compared with trivalent DTaP vaccines, no elevated risk in all-cause or non-specific mortality was seen with any quadrivalent or hexavalent DTaP vaccines, for any cohort.

Conclusion

Use of routine DTaP combination vaccines with differing disease antigens administered during the first six months of life is not associated with infant mortality.  相似文献   
4.
OBJECTIVE: Nocturnal enuresis is a common pediatric problem, the etiology of which is unclear. In recent years, various studies have been published stating that children with nocturnal enuresis exhibit growth and skeletal maturation retardation. METHODS: In this cross-sectional study, we included 27 patients (16 boys, 11 girls) between the ages of 6 and 14 years who had presented with primary nocturnal enuresis (PNE) complaints. We included in the evaluation 19 healthy subjects (12 boys, 7 girls), who were the siblings of the children with PNE, as the control group. RESULTS: The patients in both groups were similar in chronological age, bone age, height and weight, with no significant difference between groups (P>0.05). CONCLUSION: The two groups in our study consisted of the same genetic background. Thus, our results were found to be different from the previous studies. We have concluded that there is no direct relationship between enuresis nocturnal and skeletal maturation.  相似文献   
5.
The computed tomography manifestations of Kaposi's sarcoma in the stomach have not been described. A case of autoimmune deficiency syndrome-related Kaposi's sarcoma with stomach involvement documented on computed tomography is presented.  相似文献   
6.
1. Rhesus monkeys were equipped with a novel intracerebroventricular (i.c.v.) cannula system and trained to respond under operant schedules of food presentation or termination of stimuli associated with the delivery of shock (escape). 2. CRH decreased food-maintained behavior in a dose-related manner over the range of (0.3-10 micrograms/kg) but did not affect escape responding, demonstrating a selective effect on food-maintained responding. 3. This selective effect was related to the tendency for responding to stop after delivery of a food pellet when higher doses of CRH were given, consistent with the notion that a conditioned aversion to food was established in the presence of CRH. 4. This may suggest that in hyperaroused clinical states such as depression and anorexia nervosa, focus is shifted away from appetitive tasks as a result of increased levels of CRH.  相似文献   
7.
Many polycyclic aromatic hydrocarbons containing peripherallyfused cyclopenta rings are believed to be activated primarilyby epoxidation of the cyclopenta ring. The cyclopenta epoxidesof a series of four cyclopenta benzanthracene derivatives, benz[e]aceanthrylene-5,6-oxide,benz[j]ace-anthrylene-1,2-oxide, benz(l)anthrylene-1,2-oxideand benz[k]acephenaceanthrylene-4,5-oxide were synthesized fromtheir parent hydrocarbons by formation of the bromohydrin followedby dehydrobromination, and characterized by u.v. – vis,and 1H n.m.r. spectroscopy and mass spectrometry. The mutagenicityof these compounds was investigated in the Ames plate incorporationassay with Salmonella typhimurium strain TA98. All the oxideswere active without exogenous metabolic activation (170–320His+ revertants per nanomole) and also toxic above 0.5 µg/plate.Addition of S9 protein did not increase, and generally decreased,the mutagenicity of the oxides, while toxicity was largely unchanged.These results are consistent with the postulated role of cyclopentaoxides as major contributors to the mutagenicity of the parentcompounds in the Ames assay.  相似文献   
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号